Introduction
Diabetes mellitus is a complex and a multifarious group of disorders that disturbs the metabolism of carbohydrates, fat and protein. It results from shortage or lack of insulin secretion or reduced sensitivity of the tissue to insulin [1] . Diabetes is a chronic medical condition, it can be controlled by medication and lifestyle modification throughout the life span. The clinical manifestation leading damage to the small blood vessels, referred to as microvascular disease. Diabetes is also an important factor in accerating the hardening and narrowing the arteries (atherosclerosis), leading to strokes, coronary heart disease, and other large blood vessel diseases. This is referred to as macrovascular diseases [2] .
Currently there are over 150 million diabetics worldwide and this is likely to increase to 300 million or more by the year 2025 [3] [4] .Statistical projection about India suggest that the number of diabetics will rise from 15 million in 1995 to 57 million in the year 2025 making it the country with highest number of diabetics in the world [3] . This dreadful disease is found in all parts of world and is becoming a serious threat to mankind. A lot of synthetic chemical agents are available to control and treat diabetic patients, but total recovery from diabetes has not been reported till the date. Plants provide a potential source of hypoglycemic drugs and are widely used in several traditional system of medicine. The effects of these plants may delay the development of diabetic complications and correct the metabolic abnormalities by various mechanisms [5] . Currently available oral antihyperglycemic agents in clinical use have characteristic profile of side effects. Management of diabetes with agents devoid of any side effects is still a challenge to the medical system. This has led to an increase in the demand for natural products with antihyperglycemic activity having fewer side effects [6] . It is therefore imperative that the larger number of crude drugs which are in use as complementary and alternative medicine claiming to be useful in diabetes, be subjected to scientific evaluation. Traditional antidiabetic plants might provide a new oral hypoglycemic compounds, which can counter the high cost and poor availability of the current medicine present day drugs for many rural populations in developing countries [7] [8] .
Trema orientalis(L.)Blumeis a species of flowering tree in the hemp family Cannabaceae. This common tree is widely used in African folk medicine for many diseases, for example asthma, cough, dysenteria and hypertension [9] .The root of this plant has been used for treatment of trauma, blood stasis, hematuria and bleeding of intestine and stomach [10] [11] .The root, bark and leaves are used in epilepsy. The stem bark is used as a poultice for muscular pain [12] . The study aims to scientifically evaluate whether the ethanolic leaf extract of T.orientalis has antidiabetic property.
II.
Materials And Methods
2.1Chemicals and regeants
Streptozotocin obtained from Himedia (Mumbai, India). Nicotinamide and glibenclamide were obtained from (Alcon Pharmaceuticals, Mumbai). All other chemicals and reagents used were of analytical grade.
Plant materials
The fresh leaves of T. orientaliswere collected fromKottayam M G University Campus on 5 th April 2012. The plant was identified and authenticated from School of Environmental science, M.G University, Kottayam. A voucher specimen (SES.M.G.UTY NO. 1458) is preserved at the Herbarium of School of Environmental science, M.G University, Kottayam.Freshly collected plant materials were washedunder running tap water and distilled water to removeadhering dust and then dried under shade. The driedsamples were powdered in a Mechanical grinder and usedfor solvent extraction.
Solvent extraction
The extraction of the dried powdered plant samples were carried out by hot continuous extraction method in Soxhlet extractor with ethanol as solvent for 10 h. The extract obtained was collected and concentrated by gentle heating followed by using vacuum evaporator. The concentrated extract was weighed and the percentage yield was calculated. Then the extract was subjected to Preliminary Phytochemical Evaluation.
Pharmacological evaluation 2.4.1Experimental animals
Healthy adult Wistar male albino rats between 4 to 8 weeks of age and weighing about 150-250 g were used for the study. Animals were procured from the animal house of University College of Pharmacy, Cheruvandoor. Housed in polypropylene cages at a temperature of 25-30˚C and relative humidity 35 -45%, light and dark cycles of 12 and 12 h respectively for one week before and during the experiments. Animals were provided with standard rodent pellet diet (Dayal Industries, Banglore) and the food was withdrawn 12-18 h before the experiment though water was allowed ad libitum. All studies were performed in accordance with the guide for the care and use of laboratory animals, and approved by the Institutional Animal Ethical Committee of UCP, Cheruvandoor, Kottayam, India (010/MPH/UCP/CVR/12).
Preparation of the test samples
Extract as well as drug was suspended in 0.5% carboxymethyl cellulose (CMC) in distilled water prior to oral administration to the experimental animals.
Effect Of Ethanolic Extract Of T.orientalis Leaves In Normoglycemic Rats
Effect of EETO in normoglycemic rats was evaluated by a method described by Shirwaikar et al [13] .For normoglycaemic study, over night fasted animals were randomly divided into four groups of six anmals each. Group I -Normal Control rats received vehicle solution. Group IINormal rats treated with EETO 250 mg/ kg body weight. Group IIINormal rats treated with EETO 500 mg/ kg body weight. Group IVNormal rats treated with glibenclamide 0.6 mg/ kg body weight suspended in aqueous Solution [14] .
The vehicles and the drug/extract were administered orally using intra gastric tube daily for 2 weeks. The blood samples were withdrawn from the retro orbital sinus on 1, 7 and 14 th days of extract administration. The fasting blood glucose levels were estimated by glucose oxidase-peroxidase reactive strips and a glucometer(ONE TOUCH select simple, manufactured by Johnson's & Johnson Ltd,India).
The effects of administration of EETO to diabetic rats were determined by measuring fasting blood glucose levels, serum lipid profiles, and initial and final changes in body weight. Day 7 of induction was designated as day 1 for extract administration in diabetic rats. Fasting blood glucose was estimated on days 1, 7, and 14 of extract administration using glucose oxidase-peroxidase reactive strips and a glucometer (ONE TOUCH select simple, manufactured by Johnson's & Johnson Ltd,India). All other biochemical parameters were determined on day 14 after the animals were sacrificed by cervical dislocation. Serum lipid profiles were measured by an autoanalyser (AGAPPE Diagnostics, SEACRADIM company, MISPAPLUS model) using lipid profile estimating kits (AGAPPE Diagnostic kits).
Histopathological examination [15]
Histopathological parameters were studied at the Dianova Laboratories (A Unit of Dianova Diagnostics Pvt. Ltd ), Kottayam, India, under the guidance of Dr.Rosamma Thomas MD, D.C.P.
On day 14 when the animals were sacrificed, the pancreas, of one animal from each group was excised and stored in 10% formalin after washing with normal saline. The tissue was washed, dehydrated with alcohol, cleared with xylene and paraffin blocks were made. Serial sections of 5 µm thickness were cut using a rotary microtome. The sections were then deparaffinised with xylene and hydrated in descending grades of alcohol. The slides were then transferred to haematoxylin for 10 min, followed by rinsing with water. These were examined and later counterstained with eosin, rinsed with water, dehydrated with ascending grades of alcohol, cleared with xylene and mounted and observed under light microscope for the pathological symptoms to assess any architectural changes occurring in pancreas.
Statistical analysis
Data were statistically evaluated using one-way ANOVA, followed by Dunnett's multiple comparison test using GraphPad Prism 6 version computer software. From the above tabulated data it is clear that, in normal animals treated with EETO at two dose levels (250mg/kg and 500mg/kg respectively), no significant reduction in the blood glucose level was observed as compared to the normal control (Group I).But in group IV animals (treated with 0.6 mg/kg of standard drug glibenclamide) a slight progressive decrease in blood glucose level was found during the study (p< 0.05) as compared to the normal control group.
III. Results
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Oral Glucose Tolerance Test (OGTT)
Blood glucose level of animals in all groups were recorded after every 0, 30, 60, 90 and 180 minutes. Data obtained were tabulated in the table 3.2. In this study, it was observed that within 30 minutes of starting the glucose tolerance test, blood glucose concentration almost doubled from its initial level of control. This hyperglycemia was maintained until 90minutes and then began to decrease. The three treatment groups (Group II, III,and IV) significantly blocked the elevation in blood glucose level after glucose administration, Glibenclamide blocked the hyperglycemia moderate significantly (p <0.01) at 30 minutes and highly significantly(p <0.001) at 60 and 90minutes of glucose administration as compared to normal control. The EETO at a dose level of 500 mg/kg blocked the hyperglycemia moderate significantly (p< 0.01) at 30, 60 minutes and highly significantly (p <0.001) at 90 minutes of glucose administration as compared to normal control. The EETO at a dose of 250mg/kg significantly (p<0.05) blocked the increase in blood glucose level after glucose administration from 30 minutes onwards as compared to Group I (Normal Control) animals. Progressive decrease in blood glucose level was found in all three treatment groups during study. On day 7 of extract/drug administration, in EETO 250 mg/kg treated group, EETO 500 mg/kg treated group, and Glibenclamide 0.6 mg/kg treated group, blood glucose level was decreased significantly ( p<0.05, p< 0.01 and p< 0.001 respectively) as compared to diabetic control group. At the end of experiment (on day 14), all the three treatment groups ( Group II, III and IV) showed a significant ( p<0.001) reduction in the fasting blood glucose level as compared to diabetic control rats (Group I). 
Effect of ethanolic extract of T.orientalis leaves in Streptozotocin-
Effect on serum lipid profile
In the Diabetic control group, total cholesterol and triglycerides, increased and HDL level decreased when compared to normal group. In the EETO (250 mg/kg) and Glibenclamide (0.6 mg/kg) treated groups, total cholesterol and triglycerides decreased significantly (p < 0.05, p< 0.05 respectively), while in animals treated with EETO (500 mg/kg) total cholesterol and triglycerides decreased significantly (p < 0.01) as compared to diabetic control group. In animals treated with EETO (250 mg/kg) and Glibenclamide (0.6 mg/kg),as compared to diabetic control group (Group I), HDL cholesterol increased significantly ( p< 0.05, p< 0.05 respectively), while in EETO (500 mg/kg) treated group, HDL cholesterol increased significantly at (p< 0.05). Significant change in body weight during study period was found to be in diabetic control group which decreased significantly as compared to normal control group.In animals treated with EETO (500mg/kg) and Glibenclamide (0.6 mg/kg) the body weight increased significantly (p<0.05, p<0.05 respectively) by 14 th day as compared to diabetic control group. EETO (250mg/kg) treated group animals showed a non significance increase in the body weight when compared with Group I animals. 
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IV. Discussion
Present study indicates anti-diabetic and hypolipidemic effect of ethanolic extract of Trema orientalis(L.)Blumein STZ -Nicotinamide induced type 2 diabetes in male Albino wistar rats. Over-production (excessive hepatic glycogenolysis and gluconeogenesis) and decreased utilization of glucose by the tissues are the fundamental basis of hyperglycemia in diabetes mellitus [16] . Persistent hyperglycemia, the common characteristic of diabetes can cause most of the diabetic complications. In all patients, treatment should aim to lower elevated blood glucose level to near-normal levels [17] .
OGTT referred to as the glucose tolerance test, measures the body's ability to metabolize glucose, or clear it out of the bloodstream. The test reveals how quickly glucose is metabolized from the bloodstream for use by cells as an energy source [18] . In OGTT both 250mg/kg and 500 mg/kg dose of EETO shows promising results (Table 3 .2 and Figure 3. 2), by this investigation it can be suggested that the mode of action of the EETO is probably mediated by an enhancedsecretion of insulin. Various studies on medicinal plants have reported a similar promising results in OGTT [19, 20, 15] .
Streptozotocin-Nicotinamide injection caused diabetes mellitus, which may be due to destruction of β cells of the islet of langerhans of the pancreas [15] . Streptozotocin (STZ) is a widely used chemical inducer for Type 1 diabetes. STZ has been shown to produce free radicals in the body, which specifically cut DNA chains in the pancreatic beta cells, resulting in disorder of the function of the pancreatic beta cells and at a later phase, destruction of the beta cells by necrosis. Nicotinamide dinucleotide (NA) causes activation of the poly ADP ribose synthase to repair the damaged DNA [21] . The diabetic syndrome in rats administered STZ and partially protected with suitable dosages of nicotinamide is characterized by stable moderate hyperglycemia, glucose intolerance and altered but significant glucose stimulated insulin secretion [20, 22] .
The present study observed the difference between the initial and final fasting plasma glucose levels of different groups of animal. The investigation revealed a significant elevation in blood glucose in diabetic control group as compared with normal animals at the end of the 14-day experimental period. Administration of EETO both 250mg/kg and 500 mg/kg dose to diabetic rats showed a highly significant (p < 0.001) decrease in the levels of blood glucose (Table 3. 3.1). The possible mechanism by which EETO brings about its hypoglycemic action in diabetic rats may be by potentiating the insulin effect of plasma by increasing either the pancreatic secretion of insulin from the existing beta cells or by its release from the bound form. The extract did not produce any significant effects on normal animals, which further confirms the safety and antidiabetogenic action of the extract. Various studies on medicinal plants have reported a similar blood glucose lowering activity [20, 15, 23, 33] .
Diabetes is associated with profound alterations in plasma lipid and lipoprotein profile with an increased risk of premature atherosclerosis, coronary insufficiency and myocardial infarction [24] . The most common lipid abnormalities in diabetes are hypertriglyceridemia and hypercholesterolemia [25, 26] . Accumulation of lipids in diabetes mediated through a variety of derangements in metabolic and regulatory processes, especially insulin deficiency, thereby rendering the diabetic patient more prone to hypercholesterolemia and hypertriglyceridemia.
One of the major pathogenesis of lipid metabolism disturbances in diabetes is the increased mobilization of fatty acids from adipose tissue and secondary elevation of free fatty acid level in the blood [27] .Excessive lipolysis has been found to occur during diabtes. One of the consequences of excessive mobilization of fatty acid is the production of ketone bodies in the liver. The excessive lipolysis in diabetic adipose tissue leads to increase free fatty acids in circulation. They enter the liver and are esterified to form triglycerides [14] . Fatty acids are required for both structure and function of every cell in the body and they form an important component of cell membranes. Several authors have reported that, the fatty acid compositions of various tissues are altered in both experimental and human diabetes [14, 28] . Diabetes is also known to be
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DOI: 10.9790/3008-1105011726 www.iosrjournals.org 25 | Page associated with an increases in the synthesis of cholesterol, which may be due to the increased activity of HMG CoA reductase [14] . A number of observations indicate that plasma HDL cholesterol is low in untreated insulin-deficient diabetic,which was associated with a decline in HDL-turnover rate. A marked increase in total cholesterol and decrease in HDL cholesterol have been observed in untreated diabetic rats [14] .Under normal circumstances insulin activates enzyme lipoprotein lipase and hydrolyses triglycerides. Insulin deficiency results in failure to activate the enzymes thereby causing hypertriglyceridemia [15, 14] . Hypertriglyceridemia is a common finding in patients with diabetes mellitus and is responsible for vascular complications [20] . Hypertriglyceridemia is also associated with metabolic consequences of hypercoagulability, hyperinsulinemia, insulin resistance and insulin intolerance [29] .
Lowering of serum lipids concentration through dietary or drug therapy seems to be associated with a decrease in the risk of vascular diseases.In this study, administration of the extract both 250mg/kg and 500 mg/kg dose to the STZ-Nicotinamide induced diabetic rats significantly (p <0.05, p<0.01 respectively) improved these parameters (Table 3. 3.2) . The observed hypolipidaemic effect may be because of decreased cholesterogenesis and fatty acid synthesis. Significant lowering of total cholesterol and raise in HDL cholesterol is a very desirable biochemical state for prevention of atherosclerosis and ischaemic conditions. Various studies on medicinal plants have reported a similar lipid lowering activity [27, 30, 31] .The significant control of the levels of serum lipids in the aqueous extract treated diabetic rats may be directly attributed to improvements in insulin levels upon EETO therapy.
Induction of diabetes with STZ is associated with the characteristic loss of body weight which is due to increased muscle wasting in diabetes [15] and due to loss of tissue proteins [32] . Diabetic rats treated with the EETO showed an increase in body weight as compared to the diabetic control, (Table 3. 3.3) which may be due to its protective effect in controlling muscle wasting i.e. reversal of gluconeogenesis and may also be due to the improvement in insulin secretion and glycemic control.
Histopathology studies also supported our findings. The number of functionally intact β-cells in the islet organ is of decisive importance for the development course and outcome of diabetes mellitus. The renewal of β-cells in diabetes has been studied in several animal models. The total β-cell mass reflects the balance between the renewal and loss of these cells. It was also suggested that regeneration of islet β-cells following destruction by STZ may be the primary cause of the recovery of STZ-injected rats from the effects of the drug. In our studies, the damage of pancreas in STZ-treated diabetic control rats (Figure 3 .4b) and regeneration of β -cells by glibenclamide (Figure 3.4c) was observed. The comparable regeneration was also shown by EETO at a dose of 500mg/kg (Figure 3 .4e). Histopathological data in our studies reinforce healing of pancreas, by EETO, as a plausible mechanism of their antidiabetic activity.
The phytochemical screening result showed that EETO contains high amounts of phenolics, tannins, flavanoids and terpenoids.Other constituents like saponins and alkaloids were present in low amounts. These phytochemical constituents are known to be hypoglycemic. In the light of our pharmacological studies it can assume that, the antidiabetic activity of EETO may be due to the presence of these phytoconstituents, especially due to flavanoids.Further experiment should be carried out for isolating the possible hypoglycemic and hypolipidemic compounds and then explain the actual mechanism of antidiabetic actions of the plant extract. The present study has given some preliminary idea of the hypoglycemic and hypolipidemic compounds present in the ethanolic extract of T.orientalis leaves.
This study would be helpful for the human subject to produce herbal formulation with less side effects and cost effective treatment for diabetes. Further work at biomolecular level in genetically modified diabetic rats and clinical trials of the extracts and formulations will ensure that the formulation meets the global standard and acceptability.
